Publication:
Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics

dc.bibliographiccitation.firstpage289
dc.bibliographiccitation.issue6
dc.bibliographiccitation.journalPsychiatrische Praxis
dc.bibliographiccitation.lastpage291
dc.bibliographiccitation.volume34
dc.contributor.authorGutwinski, Stefan
dc.contributor.authorMueller, Peter
dc.contributor.authorKoller, Manfred
dc.date.accessioned2018-11-07T10:59:26Z
dc.date.available2018-11-07T10:59:26Z
dc.date.issued2007
dc.description.abstractObjective The reduction of the frequency of rehospitalisation is important for improving the outcomes for patients with schizophrenia. Methods This study compares the rate of rehospitalisation between patients with antipsychotics in depot-from (n=77) and oral second-generation antipsychotics (SGA) (n=156). Results Patients with antipsychotics in depot-form had lower risk of rehospitalisation than with SGAs in oral-form after 24 months (p = 0.027) and 36 months (p = 0.018) (Kaplan-Meyer survival analysis, Log-Rank). Long intervals between two hospitalisations were found for flupentixol depot and clozapine. Conclusions Antipsychotics in depot-form require and active and close outpatient treatment, which may account for long intervals between hospitalisation improved outcomes for patients with schizophrenia.
dc.identifier.doi10.1055/s-2006-951858
dc.identifier.isi000250227400006
dc.identifier.pmid17806015
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/50697
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherGeorg Thieme Verlag Kg
dc.relation.issn0303-4259
dc.titleIntervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics
dc.typejournal_article
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections